Eli Lilly is suing four telemedicine companies selling compounded versions of its blockbuster obesity drug Zepbound and its diabetes treatment Mounjaro, escalating its battle against unauthorized sellers,

Pharmaceutical giant Eli Lilly alleges the companies are selling illegal off-brand versions of its best-selling diabetes and weight-loss drugs, Mounjaro and Zepbound.

Eli Lilly and Company (LLY) is suing four telehealth companies selling compounded versions of its weight loss drug Zepbound and its diabetes treatment Mounjaro, CNBC reported on Wednesday. The pharmaceutical giant filed lawsuits against Mochi Health,